Shoulder pain after laparoscopic cholecystectomy. Pain, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: 32 people are randomly assigned to the intervention group. who are given capsules containing Harpagaphytum. Harpagaphytum 480 mg coated tablet called Talental from
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: patient undergoing laparoscopic cholecystectomy Patient's consent to participate in the intervention and written consent Full consciousness of the patient I and II in ASA category Understanding the Persian language
Exclusion criteria
Exclusion criteria: psychiatric illness history of acute and chronic nausea and vomiting (such as gastrointestinal and ear disorders) drug and alcohol addiction Allergy to sesame pregnancy and breastfeeding history of abdominal surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale pain score of Right Shoulder. Timepoint: Patients are given one capsule the night before surgery. Subsequent doses are given every 12 hours for up to 48 hours. The time periods of measuring shoulder pain are at 0 hours (immediately after surgery) and 2, 6, 12, 24 and 48 hours after that. Method of measurement: Visual Analogue Scale.;Visual Analogue Scale pain score of left shoulder. Timepoint: Patients are given one capsule the night before surgery. Subsequent doses are given every 12 hours for up to 48 hours. The time periods of measuring shoulder pain are at 0 hours (immediately after surgery) and 2, 6, 12, 24 and 48 hours after that. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic blood pressure. Timepoint: Before induction of anesthesia, 5 minutes after insufflation of carbon dioxide gas, end of surgery. Method of measurement: Patient monitoring system.;Diastolic blood pressure. Timepoint: Before induction of anesthesia, 5 minutes after insufflation of carbon dioxide gas, end of surgery. Method of measurement: Patient monitoring system.;Heart rate. Timepoint: Before induction of anesthesia, 5 minutes after insufflation of carbon dioxide gas, end of surgery. Method of measurement: Patient monitoring system.;Respiratory rate. Timepoint: Before induction of anesthesia, 5 minutes after insufflation of carbon dioxide gas, end of surgery. Method of measurement: Patient monitoring system.;Arterial o2 saturation. Timepoint: Before induction of anesthesia, 5 minutes after insufflation of carbon dioxide gas, end of surgery. Method of measurement: Patient monitoring system.;Vomiting frequency. Timepoint: The number of times the patient vomits in 48 hours after surgery (when the intervention is finished) is recorded. Method of measurement: Frequency (asking the patient).;Nausea. Timepoint: Patients are given one capsule the night before surgery. Subsequent doses are given every 12 hours for up to 48 hours. The time periods for measuring nausea are at 0 hours (immediately after surgery) and 2, 6, 12, 24 and 48 hours after that. Method of measurement: Visual Analogue Scale.;Stomach ache. Timepoint: Patients are given one capsule the night before surgery. Subsequent doses are given every 12 hours for up to 48 hours. Abdominal pain measurement time points are 0 hours (immediately after surgery) and 2, 6, 12, 24 and 48 hours after that. Method of measurement: Visual Analogue Scale.;Ports area pain. Timepoint: Patients are given one capsule the night before surgery. Subsequent doses are given every 12 hours for up to 48 hours. The time points for measuring the pain of the ports are at 0 hours (immediately after surgery) and 2, 6, 12, 24 and 48 hours | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEbrahim Nasiri Formi
Mazandaran University of Medical Sciences
Outcome results
None listed